posted April 26, 2022 10:53 am by bossu
(229)
Aortic valve stenosis; Product developement time line -Canada projected approbation by Canada Health ;End of April and Right on time for commercialization . -FDA September -Europe Mid 2023
...read more
posted April 26, 2022 08:07 am by ddogold
(347)
Excellent news . Congrats to Louis and his whole team , and to all the longs . Next up is the FDA .
rate and reply
posted April 26, 2022 07:20 am by Possibleidiot01
(1052)
OPSENS ANNOUNCES HEALTH CANADA APPROVAL FOR ITS NEW TAVR GUIDEWIRE Canada NewswireApr 26, 2022 7:00 AM EDT QUEBEC CITY , April 26, 2022
...read more
posted April 26, 2022 07:19 am by Lesalpes29
(803)
https://www.stockwatch.com/News/Item/Z-C!OPS-3240153/C/OPS
rate and reply
posted April 21, 2022 11:14 am by ddogold
(347)
As per conference call , the company still expects Canadian approval as early as this quarter while FDA is @more likely in the second half of this year . Either way it@s all good for this hidden gem
...read more
posted April 21, 2022 11:14 am by ddogold
(347)
As per conference call , the company still expects Canadian approval as early as this quarter while FDA is more likely in the second half of this year . Either way it's all good for this
...read more
posted April 20, 2022 04:25 pm by Qccity1
(28)
Strong volume. Buyers are clearly expecting an earlier than expected approval by the FDA. This approval will open an entire new market for Opsens and will make it a perfect target for a takeover. GLTA
...read more
posted April 20, 2022 11:09 am by GoldenArm
(115)
Whoever is buying they finally figured out the potential of this company. Could also be good news coming. We shall see.
rate and reply
posted April 20, 2022 10:25 am by ddogold
(347)
It's been quite the bounce off that initial sell off from the earnings report . :)
rate and reply
posted April 20, 2022 06:36 am by Possibleidiot01
(1052)
OpSens selloff has been overdone, says Paradigm By Geordie Carragher Published on April 19, 2022 Last Updated on April 19, 2022 Filed under: All posts, Analysts, Health Stock:
...read more
posted April 19, 2022 02:58 pm by GoldenArm
(115)
Next quarter is hopefully going to get this great opportunity to the $ to $5 range or more.
rate and reply
posted April 19, 2022 02:29 pm by ivebeenthere
(87)
Great post! I think that the answers mr. Laflamme gave to the questions of the analyst just show the confidence he as in the company. The next six months will be very exciting. GLTA
rate and reply
posted April 19, 2022 02:10 pm by Possibleidiot01
(1052)
Potential catalyst - EuroPCR event, which is the biggest cardiovascular conference in Europe , May 17-20th Opsens Inc.’s (OPSSF) CEO Louis Laflamme on Q2 2022 Results – Earnings Call Transcript
...read more
posted April 15, 2022 07:22 am by retiredcf
(8753)
4/14/2022 Raymond James Set Price Target Strong-Buy C$6.00 +331.65%
rate and reply
posted April 14, 2022 04:03 pm by ddogold
(347)
Actually it closed up just shy of that 7%. As they say it's not where it begins but rather where it ends ;)
rate and reply
posted April 14, 2022 03:44 pm by ivebeenthere
(87)
On my stock analysis site there is a very strong support at 1.93 The resistance are all very weak at : 2.46 3.02 3.11 3.28 3.59
rate and reply
posted April 14, 2022 02:50 pm by jelliedeeel
(11)
Just broke resistance which was at around 2.05 There's not much in the way going forward from what I can see. What do you think is the next resistance level 2.50$ or even 3$ maybe? And still, I
...read more
posted April 14, 2022 10:27 am by Nadia6519
(235)
https://plus.lapresse.ca/screens/b2ede634-8f4e-4246-8a84-3f138afb3ec9__7C___0.html?utm_content=email&utm_source=lpp&utm_medium=referral&utm_campaign=internal+share I think you could not
...read more